Shorepoint Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $6.72M | Buy |
13,508
+60
| +0.4% | +$29.9K | 1.52% | 19 |
|
|
2024
Q4 | $7M | Buy |
13,448
+542
| +4% | +$282K | 1.6% | 18 |
|
|
2024
Q3 | $7.98M | Buy |
12,906
+117
| +0.9% | +$72.4K | 1.82% | 14 |
|
|
2024
Q2 | $7.07M | Buy |
12,789
+144
| +1% | +$79.6K | 1.66% | 17 |
|
|
2024
Q1 | $7.35M | Sell |
12,645
-618
| -5% | -$359K | 1.8% | 14 |
|
|
2023
Q4 | $7.04M | Sell |
13,263
-563
| -4% | -$299K | 1.89% | 14 |
|
|
2023
Q3 | $7M | Sell |
13,826
-616
| -4% | -$312K | 2.05% | 12 |
|
|
2023
Q2 | $7.54M | Sell |
14,442
-113
| -0.8% | -$59K | 2.12% | 12 |
|
|
2023
Q1 | $8.39M | Buy |
14,555
+690
| +5% | +$398K | 2.4% | 7 |
|
|
2022
Q4 | $7.64M | Buy |
13,865
+10,705
| +339% | +$5.89M | 2.12% | 9 |
|
|
2022
Q3 | $1.6M | Buy |
3,160
+32
| +1% | +$16.2K | 0.76% | 46 |
|
|
2022
Q2 | $1.7M | Sell |
3,128
-40
| -1% | -$21.7K | 0.72% | 52 |
|
|
2022
Q1 | $1.87M | Buy |
3,168
+49
| +2% | +$28.9K | 0.78% | 45 |
|
|
2021
Q4 | $2.08M | Sell |
3,119
-414
| -12% | -$276K | 0.84% | 46 |
|
|
2021
Q3 | $2.02M | Buy |
+3,533
| New | +$2.02M | 0.91% | 45 |
|
|
2021
Q1 | $1.62M | Sell |
3,549
-415
| -10% | -$189K | 0.87% | 44 |
|
|
2020
Q4 | $1.85M | Sell |
3,964
-104
| -3% | -$48.4K | 1.02% | 42 |
|
|
2020
Q3 | $1.8M | Sell |
4,068
-47
| -1% | -$20.8K | 1.12% | 38 |
|
|
2020
Q2 | $1.49M | Sell |
4,115
-669
| -14% | -$242K | 0.97% | 42 |
|
|
2020
Q1 | $1.36M | Buy |
4,784
+62
| +1% | +$17.6K | 1.09% | 36 |
|
|
2019
Q4 | $1.53M | Sell |
4,722
-558
| -11% | -$181K | 0.88% | 48 |
|
|
2019
Q3 | $1.54M | Sell |
5,280
-80
| -1% | -$23.3K | 0.91% | 46 |
|
|
2019
Q2 | $1.57M | Sell |
5,360
-765
| -12% | -$225K | 0.9% | 46 |
|
|
2019
Q1 | $1.68M | Buy |
+6,125
| New | +$1.68M | 0.95% | 45 |
|